LORD, ABBETT & CO. LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 24 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2014$2,444,000
-53.3%
685,000
-59.7%
0.01%0.0%
Q2 2014$5,228,000
-37.7%
1,700,000
-31.7%
0.01%
-68.4%
Q1 2014$8,390,000
+0.9%
2,490,000
+4.2%
0.02%0.0%
Q4 2013$8,317,000
-35.1%
2,390,000
-33.0%
0.02%
-36.7%
Q3 2013$12,816,000
+117.0%
3,565,000
+67.4%
0.03%
+114.3%
Q2 2013$5,907,0002,130,0000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2013
NameSharesValueWeighting ↓
MACKAY SHIELDS LLC 8,040,000$28,898,0001.55%
Baker Brothers Advisors 22,898,000$82,032,0001.17%
Amici Capital, LLC 8,000,000$28,760,0001.04%
RWC Asset Management LLP 2,000,000$7,195,0000.84%
AVIVA PLC 2,000,000$7,170,0000.06%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 5,523,000$19,810,0000.06%
LORD, ABBETT & CO. LLC 3,565,000$12,816,0000.03%
SG Americas Securities, LLC 10,000$3,595,0000.02%
FRANKLIN RESOURCES INC 7,300,000$26,244,0000.01%
DEUTSCHE BANK AG\ 5,000,000$17,960,0000.01%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders